IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.018
AS - Asia 6.972
EU - Europa 6.630
SA - Sud America 1.719
AF - Africa 696
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 34.060
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.253
SG - Singapore 3.149
CN - Cina 2.697
IE - Irlanda 1.916
UA - Ucraina 1.780
BR - Brasile 1.508
IT - Italia 1.132
CA - Canada 683
RU - Federazione Russa 547
CI - Costa d'Avorio 537
VN - Vietnam 473
SE - Svezia 296
GR - Grecia 194
GB - Regno Unito 161
KR - Corea 156
DE - Germania 131
IN - India 108
AR - Argentina 80
FI - Finlandia 69
FR - Francia 62
SN - Senegal 61
CH - Svizzera 60
BD - Bangladesh 56
MX - Messico 53
AT - Austria 51
PL - Polonia 49
UZ - Uzbekistan 49
EC - Ecuador 48
NL - Olanda 47
IQ - Iraq 42
ID - Indonesia 41
TR - Turchia 40
HK - Hong Kong 36
ZA - Sudafrica 36
ES - Italia 31
BE - Belgio 27
JP - Giappone 26
VE - Venezuela 21
MA - Marocco 18
CO - Colombia 17
NG - Nigeria 16
PK - Pakistan 16
EU - Europa 15
CZ - Repubblica Ceca 13
PE - Perù 13
PY - Paraguay 13
BG - Bulgaria 10
KE - Kenya 10
LB - Libano 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
UY - Uruguay 8
BY - Bielorussia 7
CL - Cile 7
RO - Romania 7
AL - Albania 6
JM - Giamaica 6
JO - Giordania 6
NP - Nepal 6
PH - Filippine 6
EG - Egitto 5
MY - Malesia 5
PA - Panama 5
SA - Arabia Saudita 5
TN - Tunisia 5
BH - Bahrain 4
CR - Costa Rica 4
HN - Honduras 4
OM - Oman 4
RS - Serbia 4
SI - Slovenia 4
AU - Australia 3
BO - Bolivia 3
GE - Georgia 3
IL - Israele 3
KZ - Kazakistan 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BZ - Belize 2
DZ - Algeria 2
IR - Iran 2
SK - Slovacchia (Repubblica Slovacca) 2
TV - Tuvalu 2
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
Totale 34.044
Salva come PNG Salva come JPEG
Città #
Dallas 3.100
Jacksonville 2.344
Santa Clara 2.018
Dublin 1.913
Singapore 1.868
Chandler 1.363
Boardman 922
Nanjing 637
Houston 627
Abidjan 537
Lawrence 535
Andover 530
Cambridge 529
Ashburn 506
Toronto 500
Chicago 435
Hefei 423
Catania 397
Des Moines 372
Nanchang 227
San Mateo 227
Civitanova Marche 201
Wilmington 186
Beijing 182
Hebei 173
Los Angeles 157
Seoul 156
Shenyang 151
Dong Ket 141
Athens 137
Ottawa 134
São Paulo 133
Jiaxing 115
Ho Chi Minh City 114
Tianjin 113
Saint Petersburg 112
Hanoi 89
Changsha 88
Milan 68
Dakar 61
Washington 56
Moscow 52
Council Bluffs 47
Lappeenranta 47
New York 45
Seattle 45
Brooklyn 44
Rome 44
Bremen 41
Norwalk 41
Rio de Janeiro 41
Hangzhou 38
Redondo Beach 36
Belo Horizonte 34
Hong Kong 34
Kunming 33
Jinan 32
Phoenix 30
Pune 30
Warsaw 30
Ningbo 29
Buffalo 28
Porto Alegre 27
San Francisco 27
Boston 26
Brussels 26
Curitiba 26
Atlanta 25
Montreal 25
Stockholm 25
Columbus 24
Den Haag 24
Liberty Lake 23
Palermo 23
The Dalles 23
Zhengzhou 23
Brasília 20
Helsinki 20
Guayaquil 19
Chennai 18
Gravina di Catania 18
Johannesburg 18
Tokyo 18
Campinas 17
Denver 17
Guarulhos 17
Mexico City 17
Abuja 16
Edinburgh 16
London 16
Munich 16
Ribeirão Preto 16
Salvador 16
Taizhou 16
Tashkent 16
Ann Arbor 15
Charlotte 15
Dhaka 14
Guangzhou 14
Da Nang 13
Totale 24.123
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 529
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 237
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 169
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 146
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 143
[Management of severe stenosis controversies and promises] 120
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 117
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 111
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 110
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 109
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 109
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 106
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 105
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 102
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 101
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 99
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 99
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 98
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 97
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 97
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 97
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 96
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 95
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 95
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 94
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 94
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 94
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 94
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 93
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 93
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 92
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 90
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 90
Assessment of Noninferiority Margins in Cardiovascular Medicine Trials 88
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 88
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 87
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 87
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 87
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 87
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 87
Antithrombotic Therapy in Patients with Chronic Kidney Disease 86
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 86
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 86
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 86
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 86
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 85
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 85
Clinical implication of different plaque distribution patterns in distal left main coronary artery 85
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 85
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 85
2021 ESC/EACTS Guidelines for the management of valvular heart disease 85
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 84
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 84
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 84
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 84
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes 84
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 83
Diabetes mellitus: the scary killer haunting silently 83
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 83
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 83
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 83
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 82
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 82
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 82
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 82
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 81
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 81
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 81
Contrast Transesophageal Echocardiography Using the AcuNav Ultrasound Catheter Through Mouth Way as a Guide to Percutaneous Closure of Patent Foramen Ovale 81
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 81
The year in cardiology 2017: coronary interventions 81
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 81
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 80
Transcatheter aortic valve implantation in 2017: state of the art 80
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 80
Spontaneous coronary artery dissection 79
Tailoring duration of DAPT with risk scores 79
Impact of Pentoxifylline on Platelet Function Profiles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel 79
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 79
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention 79
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes 79
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents 78
Reply: plaque rupture in stable coronary artery disease 78
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 78
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 78
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 78
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 78
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 78
CORONARY REMODELLING AFTER RECANALIZATION OF CHRONIC TOTAL OCCLUSION 78
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 78
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 77
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: a Meta-Analysis of Randomized Clinical Data 77
Quality of life assessment after percutaneous aortic valve implantation 77
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 77
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 76
Impact of race and gender on antithrombotic therapy 76
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 76
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 76
Update on clinical evidence (Part II): a summary of the main post market studies 76
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 76
Totale 9.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.634
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.466 0 0 0 0 821 112 495 6 264 24 518 226
2021/20223.761 494 579 11 50 618 12 558 99 331 5 83 921
2022/20235.180 545 67 40 349 671 985 9 814 1.432 34 172 62
2023/20242.393 125 494 111 192 100 372 50 104 17 79 472 277
2024/20258.376 96 1.246 605 325 1.999 674 153 360 706 968 450 794
2025/20266.771 1.039 914 3.400 1.186 232 0 0 0 0 0 0 0
Totale 34.843